SMI Down Around 0.5% as Global AI Selloff Hits Swiss Stocks
Published on 11/20/2026 at 13:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSwiss Stocks Under Global Tech Pressure
- The SMI was around 0.5% lower at about 10:00 CET on Friday, November 20, at approximately 14,655 points.
- By 12:08 CET, the index had fallen 0.57% to 14,637.91 points from Thursday's close of 14,721.84.
- Nestlé and Novartis limited the decline, while ABB, UBS and other technology-linked shares fell.
Swiss equities remained under pressure on Friday as renewed concerns about artificial-intelligence investment and technology valuations spread across global markets. The SMI was around 0.5% lower at about 10:00 CET at approximately 14,655 points, according to Bluewin.
Technology Shares Lead Declines
The move followed a broad retreat in technology and artificial-intelligence stocks after the strong debut of AI platform operator Anthropic failed to ease concerns about the sustainability of heavy AI infrastructure spending. Asian technology markets also suffered sharp losses, adding to the cautious tone in Europe.
ABB was among the weakest SMI constituents, falling 3.4% around 10:00 CET, while UBS also traded lower. The pressure extended to semiconductor suppliers and other technology-linked companies outside the leading index, with declines of up to 6.0% reported among AMS, Inficon, Comet, Huber+Suhner, VAT and Belimo.
Defensive Heavyweights Provide Support
Gains in Nestlé and Novartis helped prevent a steeper decline in the benchmark. Around 10:00 CET, Nestlé was up 1.2% and Novartis 0.5%, according to Bluewin. The defensive composition of the SMI therefore provided some protection as technology shares weakened across markets.
Later market data cited by finanzen.ch put the SMI at 14,637.91 points at 12:08 CET, down 0.57% from Thursday's close of 14,721.84. The index had opened at 14,694.55 points. Its Friday range at that point extended from 14,583.54 to 14,721.06 points.
Novartis Guidance Still in Focus
Thursday's 1.10% decline to 14,721.84 points followed pressure on major defensive stocks. A market summary from Swissquote said Novartis, Roche and Nestlé had weighed on the previous session, with Novartis also affected by an update to its medium-term sales-growth outlook. Investors were also monitoring interest-rate concerns and the broader retreat from risk-sensitive technology assets.
More coverage is available on the SMI topic page.
